Clinical trial Recruiting at 1 site Observational Ages 18 to 85

Identifying factors that predict recovery of consciousness in brain injury patients

Official title: Investigation of Prognostic Factors to Regain Consciousness in Neurological Early Rehabilitation

Run by BDH-Klinik Hessisch Oldendorf · NCT04445649 · Data updated 2026-11-12

This study is trying to find out what factors help predict how well patients with brain injuries will recover their awareness after they start early rehabilitation.

More Stroke trials

Quick facts

Study typeObservational
Ages18 Years to 85 Years
SexAll
Enrollment130 (estimated)
SponsorBDH-Klinik Hessisch Oldendorf
Academic / other
Locations1 site (Hessisch Oldendorf)
StatusRecruiting
StartedJune 15, 2020
Main results expectedJune 15, 2027
Study endsDecember 15, 2027
Registry record updatedOctober 1, 2026
Trial IDNCT04445649 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients with disorders of consciousness due to stroke, traumatic brain injury, or hypoxic-ischemic encephalopathy who are at least two weeks post-onset and have been admitted to an intensive care unit.

Probably not a fit

Patients with insufficient cardiorespiratory stability, severe brain injuries affecting auditory responses, or those with mental disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify prognostic factors that influence the medium and long-term outcomes of patients with disorders of consciousness (DOC) undergoing early neurological rehabilitation. A total of 130 patients will be included over 36 months, with assessments of disease severity, functional status, and various neurological measurements such as MRI and EEG conducted within the first week of admission. The primary outcome will be measured using the Coma-Recovery-Scale-Revised, with follow-ups at 3, 6, and 12 months to evaluate recovery using the Glasgow Outcome Scale-Revised. The study seeks to enhance understanding of recovery patterns in patients with DOC following severe brain injuries.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the factors that enhance recovery of consciousness, leading to improved treatment strategies for patients with severe brain injuries.

How similar studies have gone: While there have been numerous studies on prognostic factors in similar conditions, this specific approach focusing on early rehabilitation outcomes in DOC patients is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* early neurological rehabilitation (phase B)
* stroke, traumatic brain injury, hypoxic-ischemic encephalopathy
* disorder of consciousness (coma, UWS, MCS)
* at minimum two weeks after disease onset
* admission to intensive care unit
* written consent from the patient's legal representative
* exclusion of pregnancy

Exclusion Criteria:

* insufficient cardiorespiratory stability
* fractures or severe infratentorial brain injuries leading to impaired auditory evoked - potentials
* previous brain damage
* mental disorders (dementia, depression)
* colonization with multi-resistant pathogens
* MRI contraindications
* claustrophobia
* weight \> 120 kg

Where it's running

  • BDH-Clinic Hessisch Oldendorf
    Hessisch Oldendorf, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.